DE3781703D1 - 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel. - Google Patents

2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Info

Publication number
DE3781703D1
DE3781703D1 DE8787400112T DE3781703T DE3781703D1 DE 3781703 D1 DE3781703 D1 DE 3781703D1 DE 8787400112 T DE8787400112 T DE 8787400112T DE 3781703 T DE3781703 T DE 3781703T DE 3781703 D1 DE3781703 D1 DE 3781703D1
Authority
DE
Germany
Prior art keywords
derivatives
benzimidazolylalkylthio
sulfinyl
sulfonyl
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787400112T
Other languages
English (en)
Other versions
DE3781703T2 (de
Inventor
Jordi Frigola Constansa
Augusto Colombo Pinol
Juan Pares Corominas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3781703D1 publication Critical patent/DE3781703D1/de
Publication of DE3781703T2 publication Critical patent/DE3781703T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8787400112T 1986-01-20 1987-01-19 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel. Expired - Fee Related DE3781703T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8600695A FR2593178B1 (fr) 1986-01-20 1986-01-20 Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.

Publications (2)

Publication Number Publication Date
DE3781703D1 true DE3781703D1 (de) 1992-10-22
DE3781703T2 DE3781703T2 (de) 1993-02-18

Family

ID=9331254

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8787400112T Expired - Fee Related DE3781703T2 (de) 1986-01-20 1987-01-19 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE198787400112T Pending DE234980T1 (de) 1986-01-20 1987-01-19 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198787400112T Pending DE234980T1 (de) 1986-01-20 1987-01-19 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Country Status (22)

Country Link
US (1) US4791114A (de)
EP (1) EP0234980B1 (de)
JP (1) JPS62181274A (de)
KR (1) KR890002291B1 (de)
CN (1) CN1016060B (de)
AT (1) ATE80625T1 (de)
AU (1) AU587680B2 (de)
BR (1) BR8700191A (de)
CA (1) CA1296336C (de)
DD (1) DD259401A5 (de)
DE (2) DE3781703T2 (de)
DK (1) DK23887A (de)
ES (1) ES2003658A6 (de)
FR (1) FR2593178B1 (de)
GR (2) GR880300076T1 (de)
HU (1) HU197566B (de)
NO (1) NO170931C (de)
PL (1) PL154487B1 (de)
PT (1) PT84141B (de)
SU (1) SU1586513A3 (de)
YU (1) YU45932B (de)
ZA (1) ZA87343B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK8600939A (de) * 1985-03-05 1986-09-06
SE8804628D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New compounds
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2171116B1 (es) 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
GB0108592D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
RU2484089C1 (ru) * 2009-04-09 2013-06-10 Ариджен Фармасьютикалз, Инк. Тиопроизводное пиридина и фармацевтическая композиция, которая его содержит и имеет способность действовать против helicobacter pylori
AU2015308350B2 (en) 2014-08-29 2020-03-05 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (de) * 1968-10-21 1971-06-03
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4619944A (en) * 1981-06-01 1986-10-28 Usv Pharmaceutical Corporation Antihypertensive compounds

Also Published As

Publication number Publication date
FR2593178B1 (fr) 1988-04-29
GR3006109T3 (de) 1993-06-21
ZA87343B (en) 1987-08-26
PT84141A (fr) 1987-02-01
DK23887D0 (da) 1987-01-16
NO170931C (no) 1992-12-30
EP0234980A1 (de) 1987-09-02
CA1296336C (fr) 1992-02-25
AU6762187A (en) 1987-07-23
KR870007157A (ko) 1987-08-17
ATE80625T1 (de) 1992-10-15
DD259401A5 (de) 1988-08-24
PT84141B (pt) 1989-05-31
PL154487B1 (en) 1991-08-30
NO870228D0 (no) 1987-01-20
GR880300076T1 (en) 1988-12-16
BR8700191A (pt) 1987-12-08
YU45932B (sh) 1992-09-07
US4791114A (en) 1988-12-13
ES2003658A6 (es) 1988-11-01
KR890002291B1 (ko) 1989-06-28
NO870228L (no) 1987-07-21
AU587680B2 (en) 1989-08-24
CN1016060B (zh) 1992-04-01
SU1586513A3 (ru) 1990-08-15
DK23887A (da) 1987-07-21
EP0234980B1 (de) 1992-09-16
NO170931B (no) 1992-09-21
CN87100363A (zh) 1987-09-02
PL263733A1 (en) 1988-07-07
YU6087A (en) 1988-08-31
HU197566B (en) 1989-04-28
DE234980T1 (de) 1988-02-25
DE3781703T2 (de) 1993-02-18
JPS62181274A (ja) 1987-08-08
FR2593178A1 (fr) 1987-07-24
HUT44781A (en) 1988-04-28

Similar Documents

Publication Publication Date Title
DE3764828D1 (de) Derivate von n-alpha-arylsulfonylaminoacyl-p-amidino-phenylalaninamiden, verfahren zu deren herstellung, deren verwendung als arzneimittel und deren zwischenverbindungen.
ATE79377T1 (de) Neue picolinderivate, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel.
ATE62683T1 (de) Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
ATE146787T1 (de) Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln
ATE103603T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und deren therapeutische anwendung.
DE3667660D1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
AT363936B (de) Verfahren zur herstellung von neuen cyproheptadinderivaten und von deren pharmazeutisch verwendbaren salzen sowie optischen isomeren
DE3781703D1 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
ATE489T1 (de) Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung.
ATE2794T1 (de) 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE121396T1 (de) Dibenzo(1,5)dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung.
ATE9330T1 (de) Phenethanolamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE103907T1 (de) Cyclopropyl-substituierte azolylmethylcarbinole, verfarhren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3678470D1 (de) Neue 3-pyridylmethylnaphthylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69112432T2 (de) Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
DE3774367D1 (de) Oxolabdane, verfahren zu deren herstellung und deren verwendung als arzneimittel.
DE3785987D1 (de) Imidazol-derivate und deren salze, verfahren zu deren herstellung, deren anwendung als arzneimittel und deren zusammensetzungen.
DE3750396T2 (de) Optisch aktive 2,3-Dihydrobenzoxazinderivate und Verfahren zu deren Herstellung.
ATE23159T1 (de) 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-py imido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE61054T1 (de) 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE3862404D1 (de) Benzylaminoaryl-dihydropyridinelactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee